Immunitybio Stock Price History
IBRX Stock | USD 2.75 0.08 2.83% |
Below is the normalized historical share price chart for Immunitybio extending back to July 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunitybio stands at 2.75, as last reported on the 21st of July, with the highest price reaching 2.94 and the lowest price hitting 2.73 during the day.
If you're considering investing in Immunitybio Stock, it is important to understand the factors that can impact its price. At this stage we consider Immunitybio Stock to be unstable. Immunitybio holds Efficiency (Sharpe) Ratio of 0.0318, which attests that the entity had a 0.0318 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Immunitybio, which you can use to evaluate the volatility of the firm. Please check out Immunitybio's Risk Adjusted Performance of 0.018, market risk adjusted performance of 0.0275, and Downside Deviation of 5.39 to validate if the risk estimate we provide is consistent with the expected return of 0.16%.
At this time, Immunitybio's Common Stock Total Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 3 B in 2025, despite the fact that Total Stockholder Equity is likely to grow to (463.7 M). . Price To Sales Ratio is likely to drop to 115.01 in 2025. Price Earnings Ratio is likely to drop to -4.53 in 2025. Immunitybio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of July 2015 | 200 Day MA 3.2734 | 50 Day MA 2.7458 | Beta (0.07) |
Immunitybio | Build AI portfolio with Immunitybio Stock |
Sharpe Ratio = 0.0318
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | IBRX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.95 actual daily | 44 56% of assets are more volatile |
Expected Return
0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Immunitybio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunitybio by adding it to a well-diversified portfolio.
Enterprise Value Ebitda (8.99) | Price Sales 77.7402 | Shares Float 130.9 M | Wall Street Target Price 11.4 | Earnings Share (0.57) |
Immunitybio Stock Price History Chart
There are several ways to analyze Immunitybio Stock price data. The simplest method is using a basic Immunitybio candlestick price chart, which shows Immunitybio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | June 9, 2025 | 3.44 |
Lowest Price | May 7, 2025 | 1.89 |
Immunitybio July 21, 2025 Stock Price Synopsis
Various analyses of Immunitybio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immunitybio Stock. It can be used to describe the percentage change in the price of Immunitybio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immunitybio Stock.Immunitybio Price Rate Of Daily Change | 0.97 | |
Immunitybio Price Daily Balance Of Power | (0.38) | |
Immunitybio Price Action Indicator | (0.12) |
Immunitybio July 21, 2025 Stock Price Analysis
Immunitybio Stock Price History Data
The price series of Immunitybio for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 1.55 with a coefficient of variation of 10.63. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.7. The median price for the last 90 days is 2.71.Open | High | Low | Close | Volume | ||
07/21/2025 | 2.83 | 2.94 | 2.73 | 2.75 | ||
07/21/2025 | 2.83 | 2.94 | 2.73 | 2.75 | ||
07/18/2025 | 2.89 | 2.94 | 2.73 | 2.75 | 7,049,272 | |
07/17/2025 | 2.75 | 2.87 | 2.74 | 2.83 | 7,246,529 | |
07/16/2025 | 2.77 | 2.82 | 2.71 | 2.75 | 6,405,734 | |
07/15/2025 | 2.92 | 2.95 | 2.70 | 2.74 | 6,753,645 | |
07/14/2025 | 2.81 | 2.94 | 2.78 | 2.90 | 5,664,169 | |
07/11/2025 | 2.88 | 2.95 | 2.80 | 2.81 | 6,028,117 | |
07/10/2025 | 2.77 | 2.91 | 2.74 | 2.87 | 5,284,525 | |
07/09/2025 | 2.75 | 2.91 | 2.74 | 2.79 | 7,891,728 | |
07/08/2025 | 2.76 | 2.78 | 2.68 | 2.71 | 6,011,786 | |
07/07/2025 | 2.90 | 3.00 | 2.70 | 2.72 | 8,582,087 | |
07/03/2025 | 2.71 | 2.75 | 2.65 | 2.72 | 3,275,284 | |
07/02/2025 | 2.56 | 2.77 | 2.55 | 2.64 | 6,770,763 | |
07/01/2025 | 2.60 | 2.69 | 2.50 | 2.57 | 5,301,866 | |
06/30/2025 | 2.74 | 2.79 | 2.62 | 2.64 | 5,152,143 | |
06/27/2025 | 2.79 | 2.81 | 2.66 | 2.70 | 15,442,314 | |
06/26/2025 | 2.75 | 2.82 | 2.74 | 2.79 | 3,494,752 | |
06/25/2025 | 2.80 | 2.80 | 2.65 | 2.76 | 5,272,418 | |
06/24/2025 | 2.79 | 2.87 | 2.77 | 2.79 | 4,486,812 | |
06/23/2025 | 2.81 | 2.87 | 2.64 | 2.76 | 6,719,114 | |
06/20/2025 | 2.86 | 2.93 | 2.83 | 2.87 | 9,117,959 | |
06/18/2025 | 2.87 | 2.96 | 2.83 | 2.84 | 5,555,582 | |
06/17/2025 | 3.12 | 3.12 | 2.77 | 2.84 | 9,589,183 | |
06/16/2025 | 3.08 | 3.24 | 3.04 | 3.13 | 7,121,160 | |
06/13/2025 | 3.03 | 3.16 | 3.01 | 3.07 | 16,722,056 | |
06/12/2025 | 3.19 | 3.37 | 3.17 | 3.19 | 8,666,639 | |
06/11/2025 | 3.34 | 3.40 | 3.21 | 3.24 | 8,691,229 | |
06/10/2025 | 3.50 | 3.76 | 3.33 | 3.34 | 16,636,938 | |
06/09/2025 | 3.29 | 3.53 | 3.23 | 3.44 | 25,895,039 | |
06/06/2025 | 2.95 | 3.32 | 2.95 | 3.15 | 18,800,199 | |
06/05/2025 | 2.90 | 3.02 | 2.83 | 2.90 | 7,129,960 | |
06/04/2025 | 2.75 | 2.98 | 2.66 | 2.93 | 11,295,370 | |
06/03/2025 | 2.73 | 2.79 | 2.62 | 2.71 | 8,402,949 | |
06/02/2025 | 2.77 | 2.88 | 2.65 | 2.67 | 12,131,760 | |
05/30/2025 | 2.61 | 2.71 | 2.51 | 2.66 | 9,449,387 | |
05/29/2025 | 2.50 | 2.65 | 2.46 | 2.60 | 6,443,173 | |
05/28/2025 | 2.52 | 2.56 | 2.43 | 2.46 | 4,312,855 | |
05/27/2025 | 2.71 | 2.79 | 2.52 | 2.53 | 7,725,802 | |
05/23/2025 | 2.59 | 2.63 | 2.47 | 2.53 | 6,254,280 | |
05/22/2025 | 2.64 | 2.75 | 2.58 | 2.68 | 8,131,319 | |
05/21/2025 | 2.86 | 2.91 | 2.64 | 2.65 | 9,679,102 | |
05/20/2025 | 2.89 | 3.06 | 2.78 | 2.90 | 12,477,410 | |
05/19/2025 | 2.83 | 2.89 | 2.67 | 2.80 | 10,258,383 | |
05/16/2025 | 2.69 | 2.91 | 2.67 | 2.84 | 8,727,405 | |
05/15/2025 | 2.51 | 2.74 | 2.47 | 2.67 | 9,328,516 | |
05/14/2025 | 2.51 | 2.59 | 2.39 | 2.49 | 9,763,335 | |
05/13/2025 | 2.42 | 2.62 | 2.33 | 2.51 | 14,868,552 | |
05/12/2025 | 2.26 | 2.46 | 2.20 | 2.36 | 12,700,740 | |
05/09/2025 | 2.10 | 2.21 | 2.03 | 2.07 | 6,525,285 | |
05/08/2025 | 1.98 | 2.17 | 1.91 | 2.09 | 17,767,211 | |
05/07/2025 | 2.01 | 2.01 | 1.83 | 1.89 | 14,740,113 | |
05/06/2025 | 2.10 | 2.27 | 1.96 | 2.01 | 22,458,381 | |
05/05/2025 | 2.27 | 2.42 | 2.00 | 2.10 | 31,014,114 | |
05/02/2025 | 2.54 | 2.63 | 2.53 | 2.54 | 3,788,099 | |
05/01/2025 | 2.54 | 2.54 | 2.43 | 2.49 | 3,131,236 | |
04/30/2025 | 2.45 | 2.51 | 2.41 | 2.51 | 3,469,777 | |
04/29/2025 | 2.62 | 2.63 | 2.48 | 2.49 | 4,430,991 | |
04/28/2025 | 2.65 | 2.78 | 2.58 | 2.63 | 3,701,124 | |
04/25/2025 | 2.67 | 2.67 | 2.55 | 2.61 | 3,289,108 | |
04/24/2025 | 2.70 | 2.73 | 2.63 | 2.69 | 3,360,030 |
About Immunitybio Stock history
Immunitybio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunitybio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunitybio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunitybio stock prices may prove useful in developing a viable investing in Immunitybio
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 700.4 M | 471.1 M | |
Net Loss | -374.9 M | -356.2 M |
Immunitybio Stock Technical Analysis
Immunitybio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Immunitybio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunitybio's price direction in advance. Along with the technical and fundamental analysis of Immunitybio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunitybio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.018 | |||
Jensen Alpha | (0.28) | |||
Total Risk Alpha | (0.67) | |||
Sortino Ratio | (0.02) | |||
Treynor Ratio | 0.0175 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.